We previously discovered a splice variant of choline acetyltransferase (ChAT) mRNA, and designated the variant protein pChAT because of its preferential expression in peripheral neuronal structures. In this study, we examined the immunohistochemical localization of pChAT in rat cochlea and compared the distribution pattern to those of common ChAT (cChAT) and acetylcholinesterase. Some neuronal cell bodies and fibers in the spiral ganglia showed immunoreactivity for pChAT, predominantly the small spiral ganglion cells, indicating outer hair cell type II neurons. In contrast, cChAT-and acetylcholinesterase-positive structures were localized to fibers and not apparent in ganglion cells. After ablation of the cochlear nuclei, many pChAT-positive cochlear nerve fibers became clearly visible, whereas fibers immunopositive for cChAT and acetylcholine esterase disappeared. These results suggested that pChAT and cChAT are localized in different systems of the rat cochlea; pChAT in the afferent and cChAT in the efferent structures.
I. Introduction
Acetylcholine (ACh) is traditionally thought of as the neurotransmitter of the cochlea efferent system, since the report of Schuknecht and colleagues in 1959 [2, 12, 25, 35, 38] , and indeed, ACh localizes exclusively to the basal and middle regions of the cochlea [1, 15, 16] . On the other hand, little is known about the transmitter substances of the afferent system.
Choline acetyltransferase (ChAT) [17, 20, 31, 46] and acetylcholine esterase (AChE) [18, 26, 39, 40] have long been used as markers of cholinergic innervation of the cochlea. In particular, immunohistochemistry for ChAT is considered the most reliable histochemical technique for visualizing cholinergic structures [4, 11, 13, 23, 24, 29] . However, while powerful in revealing central cholinergic structures, most of the available antibodies against ChAT often fail to show peripheral cholinergic nerves, indicating a possible difference between the molecular forms of ChAT expressed in the central and peripheral nervous systems.
We previously demonstrated a splice variant of ChAT mRNA, of which the product is expressed preferentially in the peripheral nervous system [45] . We named this variant product ChAT of a peripheral type (pChAT), while we proposed the term ChAT of a common type (cChAT) for conventional ChAT. Using a rabbit antiserum raised against pChAT, we provided immunohistochemical evidence of the variant protein expression in most neurons of the rat pterygopalatine ganglion, which is composed mainly of cholinergic cells, while no pChAT-immunopositive neurons were apparent in the rat forebrain. These findings suggested that the variant ChAT protein is expressed exclusively in peripheral cholinergic cells.
Immunohistochemistry using pChAT antiserum has subsequently confirmed the presence of cholinergic systems in the peripheral nervous system [3, 6, 9, 10, 19, 27, 32-34, 37, 47-51] . Interestingly, the possible existence of pChAT-positive neurons was also reported in various sensory ganglia such as the trigeminal ganglia [27, 48, 49, 51] , nodosa ganglia [33, 34] , and dorsal root ganglia [3] .
To evaluate the immunohistochemical distribution of pChAT-positive structures in the rat cochlea, we employed immunohistochemical methods using pChAT antiserum. We also compared the distribution patterns of cChAT and AChE with that of pChAT, as well as the relative immunolocalization of pChAT after surgical removal of the cochlear nucleus, in order to understand the trajectory of pChAT-positive fibers and neuronal cell bodies in the cochlea.
II. Materials and Methods

Animals
Adult male Wistar rats (Clea Japan Inc., Japan) weighing approximately 200 g were used in this study. Animals were kept in laboratory conditions under a 12-hr dark/light cycle. All procedures were carried out in accordance with the Public Health Service Policy on the Humane Care and Use of Laboratory Animals, the NIH Guide for the Care and Use of Laboratory Animals, and the Animal Welfare Act (7 U.S.C. 2131 et seq.). The Institutional Animal Care and Use Committee of the Shiga University of Medical Science approved all experimental protocols.
Tissue preparations
Under pentobarbital anesthesia (80 mg/kg), the animals (n=10) were perfused via the ascending aorta with 10 mM ice-cold phosphate-buffered saline (pH 7.4) followed by a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The rats were kept in crushed ice during the perfusion, after which the temporal bones including the inner ear and brains were excised and postfixed in 4% paraformaldehyde for 48 hr at 4°C. The tissues were then incubated overnight in 10% sucrose in phosphate buffer, and then cut into 20-µm sections on a cryostat. The temporal bone specimens were stored for approximately 3 weeks in 10% sodium ethylenediamine-tetraacetic acid solution for decalcification, and then immersed for 30 min in 0.1 M phosphate buffer (pH 7.4) containing 10% gelatin at 37°C and then at 4°C for 1 hr. After cryoprotection for 2 days by immersion in 0.1 M phosphate buffer (pH 7.4) containing 15% sucrose, the tissues were cut into 20-µm sections on a cryostat, and collected into 0.1 M phosphatebuffered saline (pH 7.4) containing 0.3% Triton X-100 (PBST).
Characterization of antibodies
For immunohistochemical staining of cChAT, we used a goat polyclonal anti-cChAT antibody that reacts by immunoblotting to protein bands with an apparent molecular weight of 69 kDa [3, 47] . For pChAT staining, we used a pChAT rabbit antiserum that detects a single band of 55 kDa in rat tissues by immunoblotting [3, 45] .
pChAT immunohistochemistry in the inner ear
The tissue sections were incubated as free-floating sections for 3 days at 4°C with either rabbit antiserum raised against pChAT (diluted 1 : 20,000-40,000) or goat antiserum against ChAT (diluted 1 : 10,000; AB144p, Chemicon, Temecula, CA), diluted in PBST, which was also used for washing of the section between steps. The sections were then incubated for 2 hr with biotinylated anti-rabbit IgG (diluted 1 : 1,000; Vector Laboratories, Burlingame, CA), and then for 1 hr with avidin-biotinylated peroxidase complex (diluted 1 : 2,000-4,000; Vector Laboratories) at room temperature. Peroxidase activity in the sections was visualized by reaction with 0.02% 3,3'-diaminobenzidine tetrahydrochloride, 0.0045% hydrogen peroxide, and 0.3% nickel ammonium sulfate in 50 mM Tris-HCl buffer (pH 7.6). The stained sections were mounted on gelatin-coated glass slides and air-dried. The sections were finally washed in tap water, dehydrated in a graded series of ethanol, cleared in xylene, and coverslipped with Entellan (Merck, Darmstadt, Germany) for examination under a light microscope.
For immunohistochemical controls, the pChAT antiserum was replaced with the pre-immune serum or by pChAT antiserum that had been preincubated overnight with the antigenic peptide of pChAT [45] or rat recombinant pChAT [36] . No positive staining was observed in these control experiments (data not shown).
Image analysis for pChAT in the spiral ganglion cells
We performed a semiquantitative morphometric analysis using the NIH image system to correlate the intensity of pChAT immunostaining with the size of pChATpositive cells.
AChE histochemistry
We carried out AChE histochemistry as described by Tago and colleagues [44] . After washing with 0.1 M malate buffer (pH 6.0), cochlear cryostat sections were incubated for 2 hr in 0.1 M malate buffer (pH 6.0) containing 18 µM acetylthiocholine iodide, 5 µM K3Fe(CN)6, 30 µM CuSO4, and 50 µM sodium citrate at room temperature. After washing with 50 mM Tris-HCl buffer (pH 7.6), the sections were then reacted for 20 min with 50 mM Tris-HCl buffer (pH 7.6) containing 0.02% 3,3'-diaminobenzidine and 0.0045% hydrogen peroxide with 0.3% nickel ammonium sulfate.
Surgical removal of the cochlear nucleus
To investigate changes in the distribution of efferent and afferent nerve fibers after removal of the rat cochlear nucleus unilaterally, the rat skulls were opened with a drill to expose the cerebellum under deep anesthesia with pentobarbitone sodium (50 mg/kg). The paraflocculus was then exposed and removed by aspiration. The cochlear nucleus was also removed unilaterally by aspiration under direct vision. Immunohistochemical staining with antipChAT antibody was performed in the rat temporal bone, 3 days after the treatment. Ablation of the cochlear nucleus was confirmed by examination of cresyl violet-stained sections of the brainstem.
III. Results
Immunohistochemical localization of pChAT and cChAT in the cochlea
Immunoreactivity for pChAT was localized to neuronal structures in specific areas of the rat cochlea (Fig. 1) . In particular, some cells in the spiral ganglia were intensely stained for pChAT (arrows in Fig. 1A ). Higher magnification views (Fig. 1B) revealed immunostaining for pChAT in densely packed cytoplasmic structures of mostly small spiral ganglion cells. The organ of Corti contained some nerve fibers weakly stained for pChAT (arrows in Fig. 1C ), but hair cells were pChAT-immunonegative (Fig. 1C) . Nerve fibers positive for pChAT, probably cochlear nerves, were also observed in the modiolus of the cochlea (Fig. 1D) . Figure 2 demonstrates cChAT-positive structures in the rat cochlea, wherein immunoreactivity for cChAT was detected only in some nerve fibers, such as in the modiolus (arrows in Fig. 2A, C) . Interestingly, many cChAT-positive fibers were gathered near the spiral ganglion (arrowheads in Fig. 2A ) and extended to hair cells in the organ of Corti (arrows in Fig. 2B ). Cells in the spiral ganglion were negative for cChAT (Fig. 2D) , and no positive staining was observed in the stria vascularis, inner spiral bundles, or tunnel spiral bundles.
Morphometric analysis of pChAT-positive neurons in the spiral ganglion
As mentioned above, pChAT immunoreactivity appeared to localize preferentially in small spiral ganglion cells. Morphometric analysis to confirm this visual impression showed pChAT immunoreactivity in 9.4% of the total number of spiral ganglion cells. As shown in Figure 3 , pChAT-positive cells also corresponded to smaller neurons. Figures 4A and 4B show the results of AChE histochemistry and cChAT immunohistochemistry, respectively. The pattern of distribution of AChE-positive fibers was similar to that of cChAT-positive fibers, but was fundamentally different from that of pChAT-positive fibers (Fig. 4A, B ). In agreement with previous studies, we found no AChE-positive cells in the spiral ganglion (Fig. 4A) and no overlap between AChE-positive nerve fibers and those exhibiting pChAT immunoreactivity (data not shown). 
Comparison with AChE histochemistry
Surgical removal of the cochlear nucleus
To eliminate efferent supplies to the cochlea unilaterally, the cochlear nucleus on one side of the brainstem was ablated surgically. Figures 5A and 5B show pChAT immunoreactivity in the spiral ganglion cells of the untreated and treated side after removal of the cochlear nucleus, respectively. In untreated control sections, pChAT immunoreactivity was localized to the cell bodies of some ganglionic cells. After removal of the cochlear nucleus, many pChAT-positive nerve fibers became clearly visible (arrows in Fig. 5B) . Figures 6A and 6B show cChAT immunoreactivity in the spiral ganglion of the untreated and treated side after removal of the cochlear nucleus, respectively. In contrast to pChAT, cChAT-positive structures in the treated side disappeared after removal of the cochlear nucleus (Fig. 6B) . 
IV. Discussion
The present study demonstrated the localization of pChAT-positive neurons and fibers in the spiral ganglion and modiolus of rats. The distribution patterns of pChATpositive neurons and fibers were different to those of cChAT-and AChE-positive structures. In agreement with previous AChE histochemical studies [14, 21, 22, 30, 42] , cChAT-and AChE-positive reactions were detected only in fibers, with none seen in spiral neurons. The cChATpositive nerve fibers were abolished by ablation of the cochlear nucleus, which is indicative of efferent fibers. This result is supported by many previous reports showing that ChAT activity is strongly decreased as a consequence of such lesions [2, 12, 25, 35] . The present study also demonstrated that cChAT-positive efferent fibers are associated with AChE activity, which agrees with a previous study showing reduced AChE activity after lesioning of the olivocochlear bundle in the brainstem [18] .
Although available antibodies against cChAT failed to stain any spiral ganglion cells, the pChAT antibody stained some of these cells, suggesting that some spiral ganglion cells, in particular small cells, express pChAT. After surgical removal of the cochlear nucleus, many pChAT-positive nerve fibers became clearly visible. These results suggested that pChAT protein is transported from the spiral ganglion to the cochlear nucleus. Most pChAT-positive cells were small in size and intensely stained. These small cells in the spiral ganglion were reported to be type II neurons sending sensory information from the outer hair cells (OHCs) to the brainstem [5, 7, 8, 43] . We observed that 9.4% of total ganglionic cells were immunopositive for pChAT, which agrees well with previous studies showing that the OHC type II neurons make up 5%-10% of the spiral ganglion neurons [5, 7, 8, 43] . Taken together with our results, pChAT should be a good marker for OHC type II neurons.
The OHC type II afferent fiber synapse lacks a reliable indicator of activity. The afferent innervation of this hair cell type is very minor compared with that of the inner hair cells. As a consequence, OHC type II afferent fiber activity is almost certainly masked by innervation of the predominant inner hair cells. Previous studies have suggested that this OHC afferent innervation could act to monitor the motile state (tension) of the OHCs, somewhat paralleling in function the intra-fusal fiber system in striated muscles [28] . This would imply that the innervation actually conveys "sensations of auditory pain" [8] or messages of OHC damage [41] to the cochlear nucleus in response to highintensity noises that significantly depolarize the OHC, and probably greatly alter its motile state. Neurotransmitter release could occur at that moment, in turn exciting the spiral dendrites of the type II neurons.
It remains unknown whether pChAT synthesizes ACh in the OHC afferent system. However, a recent study showed that pChAT synthesizes ACh in the dorsal root ganglia [3] , thus it is highly likely that pChAT participates in the production of ACh. Further studies are required to clarify this issue.
V. Conclusion
The localization of pChAT-positive structures was examined in the rat cochlea and compared to cChAT-and AChE-positive structures. While cChAT-and AChEpositive structures were localized to fibers, pChATimmunoreactivity was detected only in selected neurons in the spiral ganglia. These neurons are small in size and account for 9.4% of total ganglionic cells, suggesting that pChAT-positive cells are OHC type II neurons. After ablation of the cochlear nucleus, cChAT-positive fibers disappeared and pChAT-positive fibers were visible, suggesting that cChAT is localized in the efferent system and pChAT in the afferent system of the rat cochlea.
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